A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis.

about

A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis.

Item

http://www.wikidata.org/entity/Q54837286

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

A prospective clinical trial t ...... rcinoma and actinic keratosis.

@en

A prospective clinical trial t ...... rcinoma and actinic keratosis.

@nl

type

Item

label

A prospective clinical trial t ...... rcinoma and actinic keratosis.

@en

A prospective clinical trial t ...... rcinoma and actinic keratosis.

@nl

prefLabel

A prospective clinical trial t ...... rcinoma and actinic keratosis.

@en

A prospective clinical trial t ...... rcinoma and actinic keratosis.

@nl

P1476

A prospective clinical trial t ...... rcinoma and actinic keratosis.

@en

P2093

B Mühleisen

http://www.w3.org/2001/XMLSchema#string

D Jenni

http://www.w3.org/2001/XMLSchema#string

J Dreier

http://www.w3.org/2001/XMLSchema#string

J Hafner

http://www.w3.org/2001/XMLSchema#string

J Mangana

http://www.w3.org/2001/XMLSchema#string

M B Karpova

http://www.w3.org/2001/XMLSchema#string

R Dummer

http://www.w3.org/2001/XMLSchema#string

P2860

Update on HER1-3 in advanced non-small-cell lung cancer

Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors

The EGFR as a target for anticancer therapy--focus on cetuximab.

The epidemiology of skin cancer.

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

Skin cancers after organ transplantation.

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck.

Treatment of unresectable and metastatic cutaneous squamous cell carcinoma.

Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.

Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors.

P304

e000003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ESMOOPEN-2015-000003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27843579

http://www.w3.org/2001/XMLSchema#string

P932

5070204

http://www.w3.org/2001/XMLSchema#string